The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Scintimun



CIS bio InternationalEU/1/09/602/1-2

Main Information

Trade NameScintimun
Active SubstancesBesilesomab
Dosage FormKit for radiopharmaceutical preparation
Licence HolderCIS bio International
Licence NumberEU/1/09/602/1-2

Group Information

ATC CodeV09HA Technetium (99mTc) compounds
V09HA03 technetium (99mTc) antigranulocyte antibody

Status

License statusAuthorised
Licence Issued11/01/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

« Back